Differentially expressed genes (DEGs)^a showing the greatest fold changes from each potato tissue: 10 with greatest increase in expression and 10 with greatest decrease in expression. by Margaret A. Carpenter (6104180)

“…<p>Differentially expressed genes (DEGs)^a showing the greatest fold changes from each potato tissue: 10 with greatest increase in expression and 10 with greatest decrease in expression.…”

Antibiotic use in small animals by substance registration status. by Sarin Suwanpakdee (119683)

Simulated regional mean wetland seasons. by Nic Gedney (19762301)

Projected decadal changes in seasonality in the hydrological cycle over the wetland regions. by Nic Gedney (19762301)

Contemporary mean inundation fraction in the Amazon basin. by Nic Gedney (19762301)

Decadal mean regional hydrology. by Nic Gedney (19762301)

Regional contemporary (1990–1999 mean) precipitation and JULES inundation fraction over the Amazon basin. by Nic Gedney (19762301)

Changes in decadal precipitation and JULES inundation between 1990–1999 and 2089–2098. by Nic Gedney (19762301)

The contemporary, long-term seasonality in inundation over the whole of the Amazon basin. by Nic Gedney (19762301)

Percentage regional changes in decadal regional hydrology. by Nic Gedney (19762301)

Wetland classification scheme for the contemporary period. by Nic Gedney (19762301)

Wetlands over the lowland Amazon basin from the Hess product [19,20]. by Nic Gedney (19762301)

Decadal seasonality of the hydrological cycle over the wetland regions. by Nic Gedney (19762301)

Wetland classification using the ensemble simulations. by Nic Gedney (19762301)

Participants by event status and sex. by Beat Knechtle (5504402)

The small blue circles show the IC-volume (mean of left and right) from 72 males and the small red squares from 51 females as a function of age. by Pingling Kwok (14896191)

Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts. by Gillian P. McHugo (8965919)

Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

“…The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”

Scoring schemes for the assessment of skin and keel bone status in laying hens¹ [29]. by Lisa Jung (13264758)

Characteristics of the investigated laying hen flocks with numbers of assessed hens on-farm concerning skin and keel bone status. by Lisa Jung (13264758)